1-3 of 3
Andrea Borgerding
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Elderly Patients with DLBCL Failing R-CHOP: The Role of Rituximab and High Dose Therapy in Second Line Treatment. A Retrospective Analysis From the RICOVER 60 Trial.

Bertram Glass, MD, PhD, Andrea Borgerding, Marita Ziepert, Maike Nickelsen, Markus Loeffler, Prof., Michael Pfreundschuh, Lorenz H. Truemper, MD, Norbert Schmitz
Journal: Blood
Blood (2009) 114 (22): 3714.
https://doi.org/10.1182/blood.V114.22.3714.3714
Published: 2009
Journal Articles

Response to Re-Treatment with Rituximab Plus Salvage-Chemotherapy in Refractory or Relapsed Aggressive Non-Hodgkin’s Lymphoma.

Andrea Borgerding, Justin Hasenkamp, Bjoern Chapuy, Lorenz Truemper, Gerald Wulf, MD, PhD, Bertram Glass
Journal: Blood
Blood (2006) 108 (11): 4720.
https://doi.org/10.1182/blood.V108.11.4720.4720
Published: 2006
Journal Articles

Allo-Reactive NK Cells after HLA-Matched Allogeneic Hematopoietic Stem Cell Transplantation.

Justin Hasenkamp, Andrea Borgerding, Bjoern Chapuy, Gerald Wulf, PhD, MD, Inga Missal, Wolfram Jung, Lorenz Truemper, Bertram Glass
Journal: Blood
Blood (2006) 108 (11): 2904.
https://doi.org/10.1182/blood.V108.11.2904.2904
Published: 2006